PlexusDx recommends working with your healthcare team to establish baseline bloodwork before starting therapy and periodic monitoring at 3, 6, and 12 months
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
Neurodegenerative disorders peptides may enhance tissue protection, support synaptic plasticity, and reduce oxidative stress, complementing stem cell therapy in conditions such as ALS, multiple sclerosis, Parkinsons disease, and dementia
To ensure the quality of our manufactured pharmaceutical injection products, we adhere to stringent GMP guidelines at our manufacturing facilities
Alcohol: Alcohol can impair DAO function and trigger histamine release
This supplement may help in reducing inflammation, repairing small tissue, repairing brain tissue, repairing bone tissue, supporting gut health, and improving liver health